We are live on ! Find out more
WC

Wexford Capital Portfolio holdings

AUM $690M
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+18.55%
1 Year Est. Return
+57.92%
3 Year Est. Return
+92.61%
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
-$42.8M
Cap. Flow
-$200M
Cap. Flow %
-17.09%
Top 10 Hldgs %
63.83%
Holding
315
New
118
Increased
30
Reduced
60
Closed
98

Top Buys

Rank Stock Value
1
AAL icon
American Airlines Group
AAL
+$22.9M
2
AGN
Allergan plc
AGN
+$9.42M
3
MHK icon
Mohawk Industries
MHK
+$7.87M
4
AMGN icon
Amgen
AMGN
+$7.31M
5
AGN
Allergan Inc
AGN
+$6.66M

Sector Composition

Rank Sector Weight
1 Energy 60.8%
2 Healthcare 8.63%
3 Consumer Discretionary 7.28%
4 Industrials 7.26%
5 Technology 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZNGA
76
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$2.35M 0.2%
+618,665
New +$2.4M
APL
77
DELISTED
ATLAS PIPELINE PARTNERS LP UTS
APL
$2.29M 0.2%
65,324
-250,305
-79% -$9.12M
PNR icon
78
Pentair
PNR
$10.6B
$2.24M 0.19%
42,913
+28,023
+188% +$1.3M
ITB icon
79
iShares US Home Construction ETF
ITB
$2.32B
$2.04M 0.17%
+82,000
New +$1.86M
LITS
80
Lite Strategy Inc
LITS
$32.4M
$1.89M 0.16%
11,801
-3,053
-21% -$522K
GILD icon
81
Gilead Sciences
GILD
$165B
$1.88M 0.16%
25,000
-221,621
-90% -$15.4M
QCOM icon
82
Qualcomm
QCOM
$164B
$1.84M 0.16%
+24,800
New +$1.75M
DECK icon
83
Deckers Outdoor
DECK
$14.1B
$1.76M 0.15%
125,400
-69,600
-36% -$858K
MDR
84
DELISTED
McDermott International
MDR
$1.66M 0.14%
+60,467
New +$1.42M
SUNE
85
DELISTED
SUNEDISON, INC COM
SUNE
$1.63M 0.14%
+125,000
New +$1.41M
ITT icon
86
ITT
ITT
$17.1B
$1.6M 0.14%
36,900
-5,100
-12% -$203K
PFE icon
87
Pfizer
PFE
$143B
$1.55M 0.13%
+53,417
New +$1.55M
MNTA
88
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.55M 0.13%
87,750
-165,250
-65% -$2.78M
TBRA
89
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$1.55M 0.13%
36,020
-3,579
-9% -$168K
LOGM
90
DELISTED
LogMein, Inc.
LOGM
$1.51M 0.13%
+45,000
New +$1.44M
CALY
91
Callaway Golf Company
CALY
$3.28B
$1.51M 0.13%
178,661
+114,661
+179% +$910K
PPLI
92
People Inc
PPLI
$3.12B
$1.49M 0.13%
121,079
-420,775
-78% -$4.34M
KBIO
93
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$1.36M 0.12%
38,478
+3,670
+11% +$123K
VTRS icon
94
Viatris
VTRS
$20.8B
$1.3M 0.11%
30,000
-10,000
-25% -$411K
TNL icon
95
Travel + Leisure Co
TNL
$4.76B
$1.25M 0.11%
+37,655
New +$1.15M
NOK icon
96
Nokia
NOK
$46.9B
$1.18M 0.1%
145,100
-88,900
-38% -$668K
BLK icon
97
Blackrock
BLK
$167B
$1.15M 0.1%
3,643
TBI
98
Trueblue
TBI
$227M
$1.11M 0.09%
+43,000
New +$1.07M
PRGO icon
99
Perrigo
PRGO
$1.44B
$1.07M 0.09%
7,000
-20,100
-74% -$2.9M
ESRT icon
100
Empire State Realty Trust
ESRT
$1B
$1.07M 0.09%
+70,000
New +$991K

Similar funds

Wexford Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Wexford Capital held 315 positions worth $1.17B, down 3.5% from $1.21B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Wexford Capital withdrew a net $200M in Q4 2013, closing 98 positions and reducing 60 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Energy at 61% of assets, up from 57% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Wexford Capital opened a new position in American Airlines Group worth $22.4M.

  • Wexford Capital's largest Q4 2013 buy was American Airlines Group: 889,086 shares worth $22.4M.
  • Wexford Capital added most to Allergan plc in Q4 2013, an estimated $9.42M increase.
  • Wexford Capital's biggest Q4 2013 reduction was Diamondback Energy, cutting an estimated $56.6M.
  • Wexford Capital fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $31.6M.
  • Wexford Capital's ten largest holdings make up 64% of its $1.17B portfolio in Q4 2013.
  • Wexford Capital opened 118 new positions and closed 98 in Q4 2013.
  • Wexford Capital's portfolio value fell 3.5% quarter-over-quarter to $1.17B.

Based on Wexford Capital's 13F filing for Q4 2013, filed 14 Feb 2014.